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Purpose: To establish and characterize a novel untransfected corneal endothelial cell line from New Zealand white rabbits
(NRCE cell line) for studies on corneal endothelial cells.
Methods: Primary culture was initiated with a pure population of NRCE cells from corneal endothelia by successive
detachment and reattachment procedure of different durations, and cultured in 20% fetal bovine serum-containing DMEM/
F12 media with several supplements. The cell line was characterized by chromosome analysis, fluorescence immunoassay
and reverse transcription PCR. The tumorigenic potency of the cell line was examined by subcutaneous inoculation to
nude mice. The biocompatibility of the cell line to denuded amnions was examined with routine microscopic and electron
microscopic techniques.
Results: NRCE cells in primary culture proliferated to confluency in 25 days and has been subcultured to passage 227 to
date. The novel NRCE cell line, with a steady growing rate in 20% bovine calf serum (BCS)-containing DMEM/F12
medium  and  a  population  doubling  time  of  40.32  h  at  passage  191,  has  been  established.  NRCE  cells  exhibited
chromosomal aneuploidy but their modal chromosome number was still 44. The results of gene expression patterns of
marker proteins and membrane transport proteins, combined with immunofluorescent localization patterns of cell junction
proteins, indicated that NRCE cells retained normal corneal endothelial characteristics and normal expression pattern of
functional proteins. Furthermore, these cells, without any tumorigenic potency, had excellent biocompatibility to denuded
amnions in 20% BCS-containing DMEM/F12 medium, and formed confluent cell sheets attached tightly to denuded
amnions.
Conclusions: These results suggest that a novel untransfected NRCE cell line established here maintains normal corneal
endothelial characteristics and potencies to form normal cell junctions and perform normal functions of transmembrane
transport.
Mammalian corneal endothelium (MCE), essential for
maintaining  corneal  transparency,  is  composed  of  a
monolayer  of  hexagonal  endothelial  cells  with  limited
regenerative capacity after birth [1]. When too much MCE
cells are destroyed by disease or trauma, corneal edema and
blindness ensue. This kind of ensued blindness, also called
primary corneal endotheliopathy, can be cured by corneal
transplantation with normal donor corneas [2]. It is a great pity
that  most  of  the  sufferers  cannot  be  cured  by  corneal
transplantation due to a lack of donor corneas [3].
Since abundant MCE cells are absolutely necessary for
studies on corneal endothelial cells and corneal equivalent
reconstruction,  attempts  at  establishing  normal  corneal
endothelial cells have been made in rats, rabbits, bovine, cats,
and human beings [4-10]. Several immortalized MCE cell
lines  have  been  established  by  transformation  of  primary
endothelial cells with viral oncogenes [8-10]. However, these
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immortalized cell lines cannot be used for biological study and
reconstruction of tissue-engineered corneas because of their
abnormal phenotypes and latent risk of tumorigenicity [10].
Till now, primary cultures of MCE cells have been initiated
successfully, but no untransfected MCE cell lines have been
established  except  from  the  domestic  rabbit  Oryctolagus
curiculus [4-7].
New  Zealand  white  rabbits,  a  kind  of  widely  used
experimental mammals, play vital roles in medical sciences
such as toxicity testing, pyrogen testing, drug development,
and corneal transplantation. Recently, they become the most
frequently  used  mammalian  models  for  the  evaluation  of
tissue-engineered  cornea  transplantation  [11,12].
Unfortunately, no untransfected corneal endothelial cell line
from New Zealand white rabbits (NRCE cell line) had been
established by now. This study was intended to establish a
novel  untransfected  NRCE  cell  line  and  characterize  its
inherent  property,  protein  expression  pattern,  tumorigenic
potency, and its biocompatibility to denuded amnions.
METHODS
Materials: Amnions were obtained from The Eye Research
Institute of Shandong Medical Academy and their epithelia
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1070were denuded by 0.25% trypsin (Sigma-Aldrich, St. Louis,
MO).  Rabbit  corneal  keratocytes,  from  a  rabbit  corneal
keratocyte  cell  line  established  in  our  laboratory,  were
cultured  in  20%  bovine  calf  serum  (BCS)-containing
Dulbecco’s  Modified  Eagle’s  Medium/Ham’s  Nutrient
Mixture  F12  (DMEM/F12,  1:1)  medium  (Invitrogen,
Carlsbad, CA) at 37 °C with 5% CO2.
Animals: Four female New Zealand white rabbits (age range,
4–5 weeks) were used and all animal protocols were approved
by the Experimental Animal Center of Shandong Medical
Academy, in accordance with the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research.
In vitro culture of NRCE cells: Fresh eyeballs, obtained from
gas-ether  anaesthetized  New  Zealand  white  rabbits,  were
washed  twice  with  mercuric  chloride  (1:5,000)  and
disinfected in 1% gentamycin for 20 min. Each cornea was
cut off and 0.25% trypsin was infused into the hollow of flatly
placed  corneas.  Two  minutes  later,  trypsin  solution  was
discarded  and  the  corneas  were  rinsed  with  10%  BCS-
containing DMEM/F12 medium (Invitrogen). The corneas
were quartered and attached into the gelatin-coated wells of a
24 well tissue culture plate with their endothelial side down,
and cultured in 10% fetal bovine serum (FBS, Invitrogen)-
containing DMEM/F12 medium at 37 °C with 5% CO2. The
corneal fragments were detached and reattached sequentially
into a new well for different times from 6 to 48 h. Cells in the
wells containing only a pure population of NRCE cells were
collected and re-suspended in 20% FBS-containing DMEM/
F12 medium with antibiotics, and plated into two new wells.
The culture medium was further supplemented with basic
fibroblast growth factor (bFGF, 10 ng/ml), epidermal growth
factor (EGF, 10 ng/ml), N-acetylglucosamine hydrochloride
(50  μg/ml),  glucosamine  hydrochloride  (50  μg/ml),
chondroitin  sulfate  (0.8  mg/ml),  oxidation-degradation
products of chondroitin sulfate (50 μg/ml; all from Sigma-
Aldrich), carboxymethyl-chitosan (50 μg/ml; AK Scientific,
Mountain,  CA),  bovine  ocular  extracts  (5  ng/ml;  Bosen
Biological  Pharmaceutical  Inc.,  Xi’an,  China)  and  culture
supernatant of rabbit corneal keratocytes at logarithmic phase
(0.3 ml in 5 ml medium), and was refreshed at 5 day intervals
during primary culture. After a monolayer was established,
NRCE cells were subcultured with 0.25% trypsin as described
previously  [7].  From  passage  55,  NRCE  cells  were
subcultured in 20% BCS-containing DMEM/F12 medium but
without growth factors and the other supplements as described
above.
Growth properties of the NRCE cell line: Characterization of
the  growth  properties  of  passage  191  NRCE  cells  were
performed according to the procedure described by Fan et al.
[7]. The density of NRCE cell suspension used for culture
initiation was 1.73×105 cell/ml, and the cells were cultured in
20%  BCS-containing  DMEM/F12.  Three  independent
measurements were performed and the mean value of cell
density was calculated.
Chromosome analysis: Chromosome analysis of passage 191
NRCE cells, cultured in 20% BCS-containing DMEM/F12
medium, was also performed as described previously by Fan
et al [7]. The cells at logarithmic phase were administered with
60 μg/ml of colchicine (Sigma-Aldrich) for 10 h at 37 °C.
Determination  of  protein  expression  by
immunocytochemistry:  For  immunofluorescence  studies,
passage 191 NRCE cells were plated into a 24 well culture
plate  and  cultured  in  20%  BCS-containing  DMEM/F12
medium  as  described  above.  Once  90%  confluency  was
reached,  the  cells  were  washed  3  times  with  phosphate-
buffered saline (PBS). Then the cells were treated with 0.5%
Triton X-100 (Sigma-Aldrich) for 20 min at 37 °C after fixed
with 4% paraformaldehyde (Sigma-Aldrich) for 15 min. After
blocking with 5% BCS in PBS for 30 min, the cells were
washed with PBS and then incubated, respectively, with goat
anti-human zonula occludens protein 1 polyclonal antibody
(1:50; Santa Cruz Biotechnology, Santa Cruz, CA), mouse
anti-human  N-cadherin  monoclonal  antibody  (1:50;  Santa
Cruz  Biotechnology),  mouse  anti-human  connexin  43
monoclonal antibody (1:250; Chemicon, Temecula, CA) and
mouse anti-human integrin αv/β5 monoclonal antibody (1:50;
TABLE 1. REVERSE TRANSCRIPTION PCR PRIMER SEQUENCES.
mRNA Forward primer (5′−3′) Reverse Primer (5′−3′)
Amplicon
size
Accession
number
COL4A2 GTTCCAGGATGTGATGGACA TCTCCAGTGTCACCTTTGTG 371 L01477
Keratin12 GATGCTAATGCTGAGCTCGA ACCTGCCCTACAGCTTTGTA 393 X77665
FLK1 ACGGAACATCCTCTTGTCGG GCGCTCGCTTGTAACAGGTT 410 AB017155
vWF TTCATGCACTGCACCTCAAGCG GGCGTCGCACATGGGCT 380 S64544
VDAC2 GCAGTGGTGTGGAATTCTCA TAGTGTGTAGCTGGAAGTCC 441 AF209726
VDAC3 ACAGGAAAAGCGTCAGGCAA TCAAAAGCCAACACAGCCCA 290 AF209727
AQP1 TGCCACAGCCAGTGTAGTCG ACCTCGTCCCTGACCCTGAA 215 AF495880
ATP1A1 CTCTGTAACAGGGCGGTATT ATTGGCGTTGAGGTTCTTAT 219 AF235024
β-actin ATCGTGATGGACTCCGGCGA AGGAAGGAGGGCTGGAACAG 350 AF309819
Primers were designed to amplify human sequences for collagen type IV alpha 2 chain (COL4A2), vascular endothelial growth
factor receptor 2 (FLK1), von Willebrand factor (vWF ), voltage-dependent anion channel 2 (VDAC2), voltage-dependent anion
channel 3 (VDAC3), Aquaporin 1 (AQP1), and Na+-K+ ATPase alpha 1 subunit (ATP1A1).
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1071Santa Cruz Biotechnology) at 37 °C for 90 min. The cells were
washed  four  times  with  PBS  and  then  incubated  with
fluorescein (FITC)-conjugated rabbit anti-goat IgG antibody
(1:100) or FITC-conjugated goat anti-mouse IgG antibody
(Biosynthesis Biotechnology, Beijing, China) at 37 °C for 90
min.  The  cells  were  washed  five  times  with  PBS  and
visualized  with  a  Nikon  Eclipse  TE2000-U  inverted
microscope.  Omission  of  primary  antibodies  was  used  as
negative controls.
Determination of gene expression by reverse transcription
PCR:  For  determination  of  gene  expression  of  marker
proteins, primary cultured cells and established cell lines at
passage 191 were cultured in 20% BCS-containing DMEM/
F12 medium as described above. Total RNA was extracted
with  NucleoSpin  RNAII  Assay  Kit  (Macherey-Nagel,
Germany). The first strand cDNA was synthesized from 2 μg
of  the  total  RNA  in  a  20  μl  reaction  mixture  with
PrimeScriptTM  1st  strand  cDNA  Synthesis  Kit  (Takara,
Ishiyama,  Japan).  Target  genes  of  collagen  type  IV  α2
(COL4A2), keratin 12, FLK1 (vascular endothelial growth
factor receptor 2) and Von Willebrand factor (vWF; Table 1)
were then amplified in a 20 μl volume containing Tag PCR
MasterMix (Tiangen Biotech, Bejing, China) for 37 cycles by
touchdown PCR using the following parameters: 5 min at 94
°C, 10 cycles of step-down PCR consisting of 1 min at 94 °C,
50 s at 57 °C then decrease 0.5 °C each cycle until 52 °C; 1
min at 72 °C, followed by 27 cycles of 1 min at 94 °C, 50 s at
52 °C, 1 min at 72 °C, with a final extension of 5 min at 72
°C. PCR products were run on a preparative 2% agarose gel,
and the bands visualized under UV illumination. β-actin was
used as a loading control.
For  determination  of  gene  expression  of  membrane
transport proteins, target genes of voltage-dependent anion
channel  2  (VDAC2),  voltage-dependent  anion  channel  3
(VDAC3), aquaporin 1 (AQP1), and Na+/K+ ATPase alpha 1
subunit  (ATP1A1;  Table  1),  were  amplified  using  the
following parameters: 5 min at 94 °C, 10 cycles of step-down
PCR consisting of 1 min at 94 °C, 50 s at 55 °C then decrease
0.5 °C each cycle until 50 °C; 1 min at 72 °C, followed by 27
Figure 2. The growth curve of NRCE cells at passage 191. The lag
phase (Lag), logarithmic phase (Log), stationary phase (Sta), and
decline phase (Dec) were shown.
Figure 1. Morphology of NRCE cells in
vitro. A: Freshly attached NRCE cells
from corneal fragments. The non-spread
polygonal cell morphology, i.e. corneal
endothelial-like,  was  shown.  B:  The
monolayer  formed  by  NRCE  cells  in
primary culture. The plump polygonal
cell morphology was shown. C: Passage
56  NRCE  cells.  The  elongated
polygonal cell morphology was shown.
D:  Passage  227  NRCE  cells.  The
elongated  polygonal  cell  morphology
was shown. Scale bar: 100 μm.
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1072cycles of 1 min at 94 °C, 50 s at 50 °C, 1 min at 72 °C, with
a final extension of 5 min at 72 °C. β-actin was also used as a
loading control.
Assay of tumorigenic potential of NRCE cell line: Passage 191
NRCE cells at logarithmic phase were collected by trypsin
digestion  and  suspended  with  serum-free  DMEM/F12
medium. Then 0.2 ml of cell suspension with a density of
4.6×106 cell/ml was inoculated subcutaneously into one of the
forehand oxters of 4 BalB/c nude mice and the tumorigenic
status of the mice were monitored daily. After 45 days, the
skin of the oxter of inoculated mice was surgically opened and
tumorigenic status was examined. HeLa cells with a density
of 4.6×106 cell/ml inoculated into 4 BalB/c nude mice as
above were used as positive controls.
Evaluation of biocompatibility of NRCE cells with denuded
amnions: Passage 191 NRCE cells at logarithmic phase were
collected and suspended with 20% BCS-containing DMEM/
F12 medium. Then 1 ml of NRCE cell suspension with a
density of 1.73×105 cell/ml was plated into 24 well culture
plates coated with denuded amnions, and cultured at the same
conditions as described above. Culture medium was refreshed
at 5 day intervals and the morphology and growth status were
monitored daily. The morphology of cell sheets formed was
examined  with  microscopic  and  scanning  electron
microscopic  techniques,  and  the  attachment  status  of  cell
sheets and scaffold carriers was examined with transmission
electron microscopic techniques.
RESULTS
In vitro culture of NRCE cells: There were numerous pure
NRCE cells attached to the bottom of the wells after the
corneal fragments were detached (Figure 1A). These cells
were in a typical polygonal morphology and many of them
were still in the non-extended state. About 25 days later, the
primary cultured NRCE cells grew into a confluent monolayer
(Figure 1B). Most of the NRCE cells were plump and in
polygonal cell morphology. During subsequent subculture,
the polygonal morphology of NRCE cells began to elongate
to some extent after the culture medium was replaced with
20% BCS-containing DMEM/F12 medium but no growth
factors (Figure 1C). The NRCE cells grew and proliferated at
a steady rate, and their doubling time was calculated to be
40.32 h at passage 191 (Figure 2). At present, the NRCE cells
have been subcultured to passage 227 (Figure 1D), and a novel
continuous  untransfected  NRCE  cell  line  has  been
established.
Chromosome  analysis  of  NRCE  cell  line:  Chromosome
analysis showed that NRCE cells at passage 191 exhibited
chromosomal aneuploidy with chromosome numbers ranged
from 36 to 47 (Figure 3A), but the modal chromosome number
of the established NRCE cell line was still 44 (Figure 3B).
Gene expression of marker proteins and membrane transport
proteins: Among the genes of marker proteins detected by
reverse  transcription  PCR,  NRCE  cells  maintained  stable
expression of COL4A2 and FLK1, but not vWF and keratin 12
(Figure 4A), suggesting that the NRCE cell line is of corneal
endothelial  origin,  not  vascular  endothelial  or  corneal
epithelial origin. Among the genes of membrane transport
proteins detected, NRCE cells maintained stable and strong
expression of VDAC3, VDAC2, AQP1, and ATP1A1 (Figure
4B), suggesting that the NRCE cell line still maintains the
normal expression pattern of rabbit corneal endothelial cells.
Expression  of  cell  junction-related  proteins:
Immunofluorescence staining of cell junction-related proteins
showed  that  NRCE  cells  maintained  stable  expression  of
zonula occludens protein 1, E-cadherin, connexin 43, and
integrin αv/β5 (Figure 5). Various cell junctions were found
between NRCE cells under transmission electron microscope
(Figure 6). These results suggested that the established NRCE
cell line still maintains the normal expression pattern of cell
junction-related proteins of rabbit corneal endothelial cells.
Assay of tumorigenic potential of NRCE cells: Solid tumors
were found in all 4 nude mice 8 days after inoculated with
HeLa cells. However, no solid tumor was found in 4 BalB/c
nude  mice  45  days  after  passage  191  NRCE  cells  were
inoculated. The results implied that the established NRCE cell
line has no tumorigenic potency.
Biocompatibility  of  NRCE  cells  with  denuded  amnions:
Passage 191 NRCE cells grew very well on denuded amnions,
and confluent cell sheets formed 90 h later (Figure 7A,B). In
addition,  the  cell  sheets  established  tight  attachments  to
Figure  3.  Chromosome  analyses  of
NRCE  cells  at  passage  191.  A:  The
chromosomal  aneuploidy  of  NRCE
cells with chromosome numbers ranged
from 36 to 47. Among them, NRCE cells
with chromosome number of 44 were
about 51.06%. B: Chromosomes from a
NRCE cell with a number of 44.
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1073denuded amnions, almost identical to that between NRCE
cells  and  Descement's  membranes  in  vivo  (Figure  7C,D).
These results indicated that the established NRCE cell line has
excellent biocompatibility with denuded amnions.
DISCUSSION
MCE cell lines are necessary in studies of corneal endothelial
cells and reconstruction of the ocular surface with a tissue-
engineered cornea [7-10]. Even though numerous attempts
have been made to establish MCE cell lines, difficulties in
obtaining  sufficiently  pure  corneal  endothelial  cells  and
inducing  their  proliferation  need  to  be  overcome  before
initiation  of  primary  culture  and  successful  subculture
[5-10].
To  obtain  sufficiently  pure  corneal  endothelial  cells,
different efforts were made to initiate the in vitro culture of
MCE  cells,  such  as  scraping  corneal  buttons  to  gather
endothelial cells, enzymatic removal of endothelial cells from
cornea, and direct corneal fragment attachment [6,7,13,14].
To  obtain  pure  enough  NRCE  cells  for  primary  culture,
strictly controlled trypsin digestion, direct corneal fragment
attaching, and successive detaching-reattaching of different
durations,  have  been  utilized  in  this  study.  These
Figure  4.  Gene  expression  of  marker
proteins  and  membrane  transport
proteins  in  NRCE  cells.  A:  Gene
expression of marker proteins. NRCE
cells stably express collagen type IV α2
chain  (COL4A2)  and  vascular
endothelial  growth  factor  receptor  2
(FLK1), but not von Willebrand factor
(vWF) or keratin 12. B: Gene expression
of membrane transport proteins. NRCE
cells  express  voltage-dependent  anion
channel 3 (VDAC3), voltage-dependent
anion channel 2 (VDAC2), aquaporin 1
(AQP1), and Na+-K+ ATPase alpha 1
subunit  (ATP1A1).  P,  NRCE  cells  in
primary  culture;  S,  NRCE  cells  at
passage  191.  β-actin  was  used  as  a
loading control.
Figure 5. Immunofluorescence staining
patterns of junction-related proteins of
NRCE cells at passage 191. A: zonula
occludens protein 1. B: E-cadherin. C:
connexin 43. D: integrin αv/β5. Scale
bar: 100 μm.
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1074manipulations are key premises for successful initiation of
primary culture in this study.
To induce corneal endothelial cell proliferation, attempts
have been made to replenish the culture medium with different
supplements  [15].  Among  them,  chondroitin  sulfate,  a
component  of  extracellular  matrix  (ECM)  in  the  corneal
stromal layer, has been frequently used in primary culture of
corneal endothelial cells and has been shown to have a positive
effect on cell attachment, growth, and proliferation at high
concentrations  (0.8-25  mg/ml)  [14,16].  Glucosamine
hydrochloride (the main component of chondroitin sulfate)
and N-acetylglucosamine hydrochloride (an acetyl form of
glucosamine  hydrochloride)  were  also  found  to  have  a
positive effect on cell attachment and growth [17,18]. Growth
factors such as EGF and bFGF have also been found to have
a positive inducing effect on the proliferation of mammalian
corneal endothelial cells [14,19-22]. Researchers also found
that ocular extracts, containing different factors beneficial for
eye  metabolism  and  wound  healing,  could  stimulate  the
proliferation  of  corneal  endothelial  cells  [23].  Culture
supernatant  of  corneal  keratocytes  at  logarithmic  phase
contained  plenty  of  secreted  materials  including  ECM
elements (such as collagen and proteoglycans), cytokines, and
growth  factors  that  had  been  shown  to  stimulate  cell
attachment, survival, and proliferation [7,24]. Addition of all
these supplements in the culture medium is most probably the
key  premise  of  inducing  cell  proliferation  and  successful
subculture of NRCE cells in this study.
With  relatively  pure  NRCE  cells  and  supplement-
induced proliferation, a novel untransfected NRCE cell line
has been established successfully in this study. The cell line,
with the modal chromosome number of 44 and a population
doubling time of 40.32 h at passage 191, has been subcultured
to passage 227 to date.
Expression patterns of marker proteins are frequently
utilized  in  MCE  cell  line  characterization  [10,25-27].
Collagen type IV is one major type of collagen in corneal
Descemet's membrane secreted from corneal endothelial cells
that can be used as a marker protein of MCE cells [10,26].
FLK1, VEGF receptor 2, is a marker protein of both vascular
and corneal endothelial cells [27]. vWF, a large multimeric
blood  glycoprotein  required  for  normal  hemostasis,  is  a
marker protein of vascular endothelial cells [28]. Keratin-12,
an  intermediate  filament  protein  in  basal  and  suprabasal
corneal epithelial cells, is a marker protein of MCE cells [10,
29]. In this study, the expression of collagen type IV a2 and
FLK1,  but  not  vWF  and  keratin  12,  suggests  that  the
established NRCE cell line is of a corneal endothelial origin,
not of vascular endothelial or corneal epithelial origin, which
is  consistent  with  the  results  obtained  in  human  corneal
endothelial cells [30] and rabbit corneal endothelial cells [7,
10].
Membrane  transport  proteins  of  MCE  cells,  such  as
VDACs, aquaporin 1, and Na+-K+ ATPase, play crucial roles
in maintaining corneal dehydration and transparency [31,32].
Among these, VDACs are essential for anion transport [33,
34],  aquaporin  1  (AQP1)  for  osmotically  driven  water
transport [35], and Na+-K+ ATPase for maintaining corneal
dehydration  and  transparency  [36].  In  this  study,  the
maintenance of normal gene expression of VDAC2, VDAC3,
Figure  6.  Transmission  electron
microscopy of NRCE cells at passage
191.  Intercellular  junctions  (arrow
heads) were shown. Scale bar: 0.2 μm.
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1075aquaporin 1, and Na+-K+ ATPase indicated that the established
NRCE  cell  line  still  has  potencies  to  carry  out  normal
functions of transmembrane transport, which coincides with
the results obtained from immortalized NRCE cell lines [10].
Since cell junctions are absolutely necessary for MCE
cells to maintain the intact endothelium for achieving stable
corneal hydration status [37], verification of the expression of
junction proteins of NRCE cells was of great importance in
cell line characterization. So far, MCE cells are found to have
tight  junction-associated  proteins  [38],  gap  junction-
associated  proteins  [39],  anchoring  junction-associated
proteins [40], and these adhesion junction-associated proteins
mediate  and  strengthen  close  cell-cell  and  cell-matrix
associations  [18,41].  The  results  of  fluorescent
immunocytochemistry in this study showed that NRCE cells
maintained stable expression of zonula occludens protein 1
(an  intercellular  tight  junction-associated  protein),
connexin-43  (an  intercellular  gap  junction-associated
proteins),  N-cadherin  (an  intercellular  anchoring  junction-
associated  protein),  and  integrin  αv/β5  (a  cell-matrix
anchoring junction-associated protein), and the expression
levels of these proteins were similar to those of NRCE cells
in vivo (data not shown). All these results suggested that the
established NRCE cell line still maintains potency to establish
normal cell-cell and cell-extracellular matrix junctions. This
expression pattern of cell junction proteins in NRCE cells is
different  from  that  of  in  vitro  cultured  human  corneal
endothelial cells [42].
Established cell lines, especially those immortalized by
oncogene  transfections,  may  have  latent  potency  of
tumorigenicity and abnormal phenotypes [7,10]. Nude mice
were  utilized  to  verify  the  tumorigenic  potency  of  the
established  cell  line  in  this  study.  It  was  found  that  the
established  NRCE  cell  line  had  no  latent  potency  for
tumorigenicity, implying that the NRCE cell line can be used
safely  for  studies  of  normal  corneal  endothelial  cells  and
reconstruction studies of tissue-engineered corneas in rabbit
models.
Good  biocompatibility  between  corneal  cells  and
scaffold carriers is a vital precondition for reconstruction of
tissue-engineered corneas. In this study, NRCE cells, cultured
in a growth factor-free medium, could form confluent cell
sheets  on  denuded  amnions.  The  cell  sheets  were  tightly
attached to denuded amnions, almost identical to that of rabbit
corneal endothelium in vivo. The excellent biocompatibility
with denuded amnions implies that the established cell line
might  be  feasible  for  reconstruction  studies  of  tissue-
engineered corneal endothelia [12,43].
In conclusion, a novel continuous untransfected NRCE
cell line with normal characteristics and functional protein
expression has been established from New Zealand white
rabbits, and this cell line can be used for studies of normal
corneal  endothelial  cells  and  reconstruction  of  tissue-
engineered corneal endothelia in rabbit models. Functional
studies of NRCE cells and reconstruction of tissue-engineered
rabbit corneal endothelia are underway in our laboratory.
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